155 related articles for article (PubMed ID: 25596745)
1. Stimulation of hERG1 channel activity promotes a calcium-dependent degradation of cyclin E2, but not cyclin E1, in breast cancer cells.
Perez-Neut M; Shum A; Cuevas BD; Miller R; Gentile S
Oncotarget; 2015 Jan; 6(3):1631-9. PubMed ID: 25596745
[TBL] [Abstract][Full Text] [Related]
2. Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells.
Caldon CE; Sergio CM; Kang J; Muthukaruppan A; Boersma MN; Stone A; Barraclough J; Lee CS; Black MA; Miller LD; Gee JM; Nicholson RI; Sutherland RL; Print CG; Musgrove EA
Mol Cancer Ther; 2012 Jul; 11(7):1488-99. PubMed ID: 22564725
[TBL] [Abstract][Full Text] [Related]
3. Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells.
Farra R; Dapas B; Pozzato G; Scaggiante B; Agostini F; Zennaro C; Grassi M; Rosso N; Giansante C; Fiotti N; Grassi G
Dig Liver Dis; 2011 Dec; 43(12):1006-14. PubMed ID: 21831731
[TBL] [Abstract][Full Text] [Related]
4. Regulation of IGF-1-dependent cyclin D1 and E expression by hEag1 channels in MCF-7 cells: the critical role of hEag1 channels in G1 phase progression.
Borowiec AS; Hague F; Gouilleux-Gruart V; Lassoued K; Ouadid-Ahidouch H
Biochim Biophys Acta; 2011 May; 1813(5):723-30. PubMed ID: 21315112
[TBL] [Abstract][Full Text] [Related]
5. SCF(Fbxw7/hCdc4) targets cyclin E2 for ubiquitin-dependent proteolysis.
Klotz K; Cepeda D; Tan Y; Sun D; Sangfelt O; Spruck C
Exp Cell Res; 2009 Jul; 315(11):1832-9. PubMed ID: 19084516
[TBL] [Abstract][Full Text] [Related]
6. Kinase-independent function of E-type cyclins in liver cancer.
Geng Y; Michowski W; Chick JM; Wang YE; Jecrois ME; Sweeney KE; Liu L; Han RC; Ke N; Zagozdzon A; Sicinska E; Bronson RT; Gygi SP; Sicinski P
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1015-1020. PubMed ID: 29339491
[TBL] [Abstract][Full Text] [Related]
7. Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.
Caldon CE; Sergio CM; Burgess A; Deans AJ; Sutherland RL; Musgrove EA
Cell Cycle; 2013 Feb; 12(4):606-17. PubMed ID: 23324395
[TBL] [Abstract][Full Text] [Related]
8. Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control study.
Lundgren C; Ahlin C; Holmberg L; Amini RM; Fjällskog ML; Blomqvist C
Acta Oncol; 2015 Apr; 54(4):538-44. PubMed ID: 25327158
[TBL] [Abstract][Full Text] [Related]
9. Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.
Caldon CE; Sergio CM; Sutherland RL; Musgrove EA
Cell Cycle; 2013 Feb; 12(4):596-605. PubMed ID: 23324394
[TBL] [Abstract][Full Text] [Related]
10. Cx43 and AKAP95 regulate G1/S conversion by competitively binding to cyclin E1/E2 in lung cancer cells.
Chen R; Chen Y; Yuan Y; Zou X; Sun Q; Lin H; Chen X; Liu M; Deng Z; Yao Y; Guo D; Zhang Y
Thorac Cancer; 2020 Jun; 11(6):1594-1602. PubMed ID: 32338437
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
Agarwal R; Gonzalez-Angulo AM; Myhre S; Carey M; Lee JS; Overgaard J; Alsner J; Stemke-Hale K; Lluch A; Neve RM; Kuo WL; Sorlie T; Sahin A; Valero V; Keyomarsi K; Gray JW; Borresen-Dale AL; Mills GB; Hennessy BT
Clin Cancer Res; 2009 Jun; 15(11):3654-62. PubMed ID: 19470724
[TBL] [Abstract][Full Text] [Related]
12. Potassium channel activation inhibits proliferation of breast cancer cells by activating a senescence program.
Lansu K; Gentile S
Cell Death Dis; 2013 Jun; 4(6):e652. PubMed ID: 23744352
[TBL] [Abstract][Full Text] [Related]
13. The requirement for cyclin E in c-Myc overexpressing breast cancers.
Zhou Y; Geng Y; Zhang Y; Zhou Y; Chu C; Sharma S; Fassl A; Butter D; Sicinski P
Cell Cycle; 2020 Oct; 19(20):2589-2599. PubMed ID: 32975478
[TBL] [Abstract][Full Text] [Related]
14. Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer.
Spruck C; Sun D; Fiegl H; Marth C; Mueller-Holzner E; Goebel G; Widschwendter M; Reed SI
Cancer Res; 2006 Jul; 66(14):7355-60. PubMed ID: 16849587
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of cyclin E2 expression and associated kinase activity in primary breast tumors.
Payton M; Scully S; Chung G; Coats S
Oncogene; 2002 Dec; 21(55):8529-34. PubMed ID: 12466974
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells.
Wu Y; Guo X; Brandt Y; Hathaway HJ; Hartley RS
Breast Cancer Res Treat; 2011 Jun; 127(2):397-406. PubMed ID: 20607601
[TBL] [Abstract][Full Text] [Related]
17. Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines.
Aggarwal BB; Banerjee S; Bharadwaj U; Sung B; Shishodia S; Sethi G
Biochem Pharmacol; 2007 Apr; 73(7):1024-32. PubMed ID: 17240359
[TBL] [Abstract][Full Text] [Related]
18. Loss of cyclin E requirement in cell growth of an oral squamous cell carcinoma cell line implies deregulation of its downstream pathway.
Yamada S; Sumrejkanchanakij P; Amagasa T; Ikeda MA
Int J Cancer; 2004 Aug; 111(1):17-22. PubMed ID: 15185338
[TBL] [Abstract][Full Text] [Related]
19. PP2A-B55β antagonizes cyclin E1 proteolysis and promotes its dysregulation in cancer.
Tan Y; Sun D; Jiang W; Klotz-Noack K; Vashisht AA; Wohlschlegel J; Widschwendter M; Spruck C
Cancer Res; 2014 Apr; 74(7):2006-14. PubMed ID: 24509904
[TBL] [Abstract][Full Text] [Related]
20. Role of hERG1 K(+) channels in leukemia cells as a positive regulator in SDF-1a-induced proliferation.
Zheng F; Li H; Du W; Huang S
Hematology; 2011 May; 16(3):177-84. PubMed ID: 21669058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
